National Match Day is a milestone moment for graduating medical students. While the annual rite had a different tenor this year, the COVID-19 health crisis underscored for students in Weill Cornell Medical College’s Class of 2020 the value of their roles as physician trainees.
Weill Cornell Medicine scientists have built the first global database of clinical trials testing a rapidly expanding approach to cancer treatment that involves genetically modifying immune cells to recognize specific targets on a patient’s cancer cells and attack them.
More diverse applicants will be encouraged to apply to M.D.-Ph.D. programs if medical schools publish admissions statistics on their websites, a team from Weill Cornell Medicine says in a viewpoint published Dec. 9 in the Journal of Clinical Investigation.
More than 80 Weill Cornell Medicine students, faculty and senior leadership gathered Oct. 7 at Weill Cornell Medicine for a ribbon-cutting ceremony for the Feil Family Student Center, which occupies renovated first and second floors in the main campus buildings on York Avenue. The state-of-the-art center was made possible by a $12.5 million gift from the Feil Family.
Weill Cornell Medicine hosted the first-ever National Conference on Medical Student Mental Health and Well-Being Sept. 18-19, in partnership with the Association of American Medical Colleges, Associated Medical Schools of New York and the American Foundation for Suicide Prevention,
The Weill Cornell Graduate School of Medical Sciences has been awarded a competitive grant from the National Institutes of Health to launch a program dedicated to increasing the number and enhancing the success of doctoral students from underrepresented backgrounds.
Dr. Katharine Hsu, M.D. ’94, Ph.D. ’93, professor of medicine and attending physician at Memorial Sloan Kettering Cancer Center, has been awarded the Weill Cornell Graduate School Alumni Award of Distinction.
The work of global oncologists – whose insights and innovations reduce the burden of cancer around the world – has demonstrated value that academic medical leadership should consider when assessing these physicians for professional advancement, according to a commentary by Weill Cornell Medicine investigators.
Weill Cornell Medicine has experienced dynamic growth in its research enterprise over the past five years, an achievement that underscores the institution’s mission to provide patients with the most advanced treatments and therapies.